Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry
- 8 December 2013
- journal article
- Published by Springer Nature in Annals of Hematology
- Vol. 93 (5) , 811-819
Abstract
The objective of this study was to compare health-related quality of life (HRQOL) between diffuse large B cell lymphoma (DLBCL) survivors of different age categories (18–59/60–75/76–85 years) and to compare their HRQOL with an age- and sex-matched normative population. The population-based Eindhoven Cancer Registry was used to select all patients diagnosed with DLBCL from 1999 to 2010. Patients (n = 363) were invited to complete the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) questionnaire, and 307 survivors responded (85 %). Data from an age- and sex-matched normative population (n = 596) were used for comparison. DLBCL survivors aged 18–59 years scored better on physical functioning, quality of life, appetite loss and constipation than survivors of 76–85 years old (all p < 0.05). Financial problems more often occurred in survivors aged 18–59 years compared to survivors of 76–85 years old (p < 0.01). Compared to the normative population, DLBCL survivors aged 18–59 years showed worse scores on cognitive and social functioning and on dyspnea and financial problems (p < 0.01, large- and medium-size effects). In survivors of the other age categories, only differences with trivial or small-size effects were found. Although younger DLBCL survivors have better HRQOL than older survivors, the differences found between younger survivors and normative population were the largest. This suggests that having DLBCL has a greater impact on younger than older survivors and that the worse HRQOL observed in older DLBCL survivors in comparison with younger survivors is caused mostly by age itself and not by the disease.Keywords
This publication has 38 references indexed in Scilit:
- Health‐related quality of life among survivors of aggressive non‐Hodgkin lymphomaCancer, 2012
- Young adult cancer survivors' psychosocial well-being: a cross-sectional study assessing quality of life, unmet needs, and health behaviorsSupportive Care in Cancer, 2011
- Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphomaJournal of Cancer Research and Clinical Oncology, 2011
- The impact of cancer and quality of life for post‐treatment non‐Hodgkin lymphoma survivorsPsycho-Oncology, 2010
- Health status and quality of life among non‐Hodgkin lymphoma survivorsCancer, 2009
- Better quality of life among 10–15 year survivors of Hodgkin’s lymphoma compared to 5–9 year survivors: A population-based studyEuropean Journal of Cancer, 2006
- Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'AdulteJournal of Clinical Oncology, 2005
- The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinomaCancer, 2004
- The self‐administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services researchArthritis Care & Research, 2003
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993